Literature DB >> 11720678

Anaphylactic reactions to isosulfan blue dye during sentinel lymph node biopsy for breast cancer.

D Albo1, J D Wayne, K K Hunt, T F Rahlfs, S E Singletary, F C Ames, B W Feig, M I Ross, H M Kuerer.   

Abstract

BACKGROUND: Sentinel lymph node biopsy (SLNB) is an alternative to axillary dissection for many breast cancer patients. Cases of anaphylactic reaction to the isosulfan blue dye used during SLNB have recently been reported. No study on the incidence of serious anaphylactic reactions during SLNB for breast cancer has been reported.
METHODS: We reviewed 639 consecutive SLNBs for breast cancer performed at our institution. Sentinel lymph node biopsy was performed using both isosulfan blue dye and technetium-99m sulfur colloid. Cases of anaphylaxis were reviewed in detail.
RESULTS: Overall, 1.1% of patients had severe anaphylactic reactions to isosulfan blue requiring vigorous resuscitation. No deaths or permanent disability occurred. In patients with anaphylaxis, hospital stay was prolonged by a mean of 1.6 days. In 1 patient, the anaphylactic reaction required termination of the operation.
CONCLUSIONS: Prompt recognition and aggressive treatment of anaphylactic reactions to isosulfan blue are critical to prevent an adverse outcome. Lymphatic mapping with blue dye should be performed in a setting where personnel are trained to recognize and treat anaphylaxis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11720678     DOI: 10.1016/s0002-9610(01)00734-6

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  32 in total

1.  Dyed but not dead.

Authors:  Shireen H Haque; Bobby D Nossaman
Journal:  Ochsner J       Date:  2012

Review 2.  The Epidemiology of Anaphylaxis.

Authors:  Joyce E Yu; Robert Y Lin
Journal:  Clin Rev Allergy Immunol       Date:  2018-06       Impact factor: 8.667

3.  Cardiac Arrest after Patent Blue V Injection for Sentinel Lymph Node Biopsy in Breast Cancer.

Authors:  Bjorn Telgenkamp; Dennis Japink; Els van Haaren
Journal:  Breast Care (Basel)       Date:  2010-12-17       Impact factor: 2.860

4.  Hands-free, wireless goggles for near-infrared fluorescence and real-time image-guided surgery.

Authors:  Yang Liu; Adam Q Bauer; Walter J Akers; Gail Sudlow; Kexian Liang; Duanwen Shen; Mikhail Y Berezin; Joseph P Culver; Samuel Achilefu
Journal:  Surgery       Date:  2011-05       Impact factor: 3.982

5.  Positron lymphography: multimodal, high-resolution, dynamic mapping and resection of lymph nodes after intradermal injection of 18F-FDG.

Authors:  Daniel L J Thorek; Diane S Abou; Bradley J Beattie; Rachel M Bartlett; Ruimin Huang; Pat B Zanzonico; Jan Grimm
Journal:  J Nucl Med       Date:  2012-08-07       Impact factor: 10.057

Review 6.  Peri-operative anaphylaxis.

Authors:  Linda Nel; Efrem Eren
Journal:  Br J Clin Pharmacol       Date:  2011-05       Impact factor: 4.335

Review 7.  Sentinel lymph node mapping in endometrial cancer: comparison of fluorescence dye with traditional radiocolloid and blue.

Authors:  Andrea Papadia; Maria Luisa Gasparri; Alessandro Buda; Michael D Mueller
Journal:  J Cancer Res Clin Oncol       Date:  2017-08-21       Impact factor: 4.553

8.  A phase I/II trial of 125I methylene blue for one-stage sentinel lymph node biopsy.

Authors:  Jason David Cundiff; Yi-Zarn Wang; Gregory Espenan; Thomas Maloney; Arthur Camp; Laura Lazarus; Alan Stolier; Randy Brooks; Bruce Torrance; Shawn Stafford; James P O'Leary; Eugene A Woltering
Journal:  Ann Surg       Date:  2007-02       Impact factor: 12.969

9.  The Role of Blue Dye in Sentinel Node Detection for Breast Cancer: A Retrospective Study of 203 Patients.

Authors:  Jean-Remi Garbay; Dounia Skalli-Chrisostome; Nicolas Leymarie; Benjamin Sarfati; Francoise Rimareix; Chafika Mazouni
Journal:  Breast Care (Basel)       Date:  2016-04-26       Impact factor: 2.860

Review 10.  Sentinel lymph node mapping and staging in endometrial cancer: A Society of Gynecologic Oncology literature review with consensus recommendations.

Authors:  Robert W Holloway; Nadeem R Abu-Rustum; Floor J Backes; John F Boggess; Walter H Gotlieb; W Jeffrey Lowery; Emma C Rossi; Edward J Tanner; Rebecca J Wolsky
Journal:  Gynecol Oncol       Date:  2017-05-28       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.